The EU H2020 consortium EpiPredict is a group of collaborating European labs and companies that aim to understand the impact of epigenetics in the drug resistance of breast cancer treatment. Within this programme, we are responsible to train graduate students in verbal and written science communication skills by writing blogs and making videos.
|Client||EpiPredict consortium, EU Marie Skłodowska Curie Innovative Training Network|
|Period||January 2014 - September 2018|
|Location||Amsterdam, Heidelberg, London|